Article Text

Download PDFPDF
Letter
Preparation of COVID-19 vaccines in hospital pharmacies: a half-year report from Slovakia
  1. Boris Dudík1,2,
  2. Ľubica Slimáková3,
  3. Hajnalka Komjáthy4,
  4. Melisa Švecová5,
  5. Andrea Bundzelová6,
  6. Bianka Oboňová2,7,
  7. Adriána Šusterová3,
  8. Katarína Tóthová4
  1. 1 Department of Cell and Molecular Biology of Drugs, Comenius University in Bratislava, Bratislava, Slovakia
  2. 2 Pharmacy of St Elisabeth, St Elisabeth Cancer Institute, Bratislava, Slovakia
  3. 3 Hospital pharmacy, Hospital of L. Derer, University Hospital Bratislava, Bratislava, Slovakia
  4. 4 Hospital Pharmacy, AGEL General Hospital, Komárno, Slovakia
  5. 5 Hospital Pharmacy, AGEL General Hospital, Zvolen, Slovakia
  6. 6 Hospital Pharmacy, Hospital of Saints Cyril and Methodius, University Hospital Bratislava, Bratislava, Slovakia
  7. 7 Department of Chemical Theory of Drugs, Comenius University in Bratislava, Bratislava, Slovakia
  1. Correspondence to Dr Boris Dudík, Department of Cell and Molecular Biology of Drugs, Comenius University in Bratislava, Bratislava, Slovakia; dudik8{at}uniba.sk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

On 21 December 2020 the European Medicines Agency recommended the registration of the first vaccine for the prophylaxis of COVID-19 from Pfizer-BioNTech under the trade name Comirnaty.1 On 26 December the first person was vaccinated in Slovakia, and since that date vaccination has continued throughout the country. As this vaccine requires special handling and dilution before administration, it is beneficial to prepare it in sterile compounding units of hospital pharmacies.

In Europe, aseptic preparation of parenterals is considered a crucial process as errors in preparation may lead to microbial contamination of the product which poses a risk of harming the patient.2 Results from many studies indicate that pharmacists prepare syringes with less contamination than nurses thanks to their …

View Full Text

Footnotes

  • Contributors BD wrote and designed the study. LS and HK helped with design and writing the study. All authors provided data and helped with analysing and interpreting the data.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.